Weekly Dose-Dense Cisplatin-Epirubicin-Paclitaxel Administration with Granulocyte Colony-Stimulating Factor Support Does Not Substantially Improve Prognosis in Extensive Disease Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0232|68|2-3|223-229

ISSN： 0030-2414

Source： Oncology, Vol.68, Iss.2-3, 2005-07, pp. : 223-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate Cancer-Producing Granulocyte Colony-Stimulating Factor

By  

Urologia Internationalis, Vol. 82, Iss. 1, 2009-01 ,pp. : 113-115

Karger

Access to resources Recommend Favorite

Mitomycin C, Vinorelbine, Carboplatin plus Granulocyte-Macrophage Colony-Stimulating Factor for Treatment of Advanced Non-Small Cell Lung Carcinoma

By  

Oncology, Vol. 55, Iss. 6, 1998-10 ,pp. : 538-542

Karger

Access to resources Recommend Favorite

Optimal Timing (Preemptive versus Supportive) of Granulocyte Colony-Stimulating Factor Administration following High-Dose Cyclophosphamide

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 28-35

Karger

Access to resources Recommend Favorite

Granulocyte Colony‐Stimulating Factor (G‐CSF) and Granulocyte Macrophage Colony‐Stimulating Factor (GM‐CSF) in Behçet's Disease

By  

THE JOURNAL OF DERMATOLOGY, Vol. 21, Iss. 8, 1994-08 ,pp. : 546-552

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changes in Gene Expression Pattern following Granulocyte Colony-Stimulating Factor Administration to Normal Stem Cell Sibling Donors

By  

Acta Haematologica, Vol. 117, Iss. 2, 2006-11 ,pp. : 68-73

Karger

Access to resources Recommend Favorite